ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.820
-0.140 (-4.73%)
At close: Nov 4, 2025, 4:00 PM EST
2.860
+0.040 (1.42%)
After-hours: Nov 4, 2025, 6:12 PM EST
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $64.33 million as of November 4, 2025. Its market cap has increased by 845.99% in one year.
Market Cap
64.33M
Enterprise Value
67.06M
1-Year Change
845.99%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $64.33M, a decrease of -19.08%. That is a compound annual growth rate of -4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 69.70M | 805.19% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |